相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SPINAL CANNABINOID CB2 RECEPTORS AS A TARGET FOR NEUROPATHIC PAIN: AN INVESTIGATION USING CHRONIC CONSTRICTION INJURY
P. W. Brownjohn et al.
NEUROSCIENCE (2012)
CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor pain
Iryna A. Khasabova et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
Mary E. Lynch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats
Gin C. Hsieh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions
Rebecca D. Crean et al.
JOURNAL OF ADDICTION MEDICINE (2011)
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture
Tang-feng Su et al.
MOLECULAR PAIN (2011)
Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
Elizabeth J. Rahn et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy
Jennifer A. Bestard et al.
PAIN PRACTICE (2011)
Effect of Dronabinol on Central Neuropathic Pain After Spinal Cord Injury
Diana H. Rintala et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2010)
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Mark A. Ware et al.
ANESTHESIA AND ANALGESIA (2010)
Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain
V. Curto-Reyes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Mark A. Ware et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Randomized Placebo-Controlled Double-Blind Clinical Trial of Cannabis-Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy Depression is a major confounding factor
Dinesh Selvarajah et al.
DIABETES CARE (2010)
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
Jeremy R. Johnson et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons
Uma Anand et al.
MOLECULAR PAIN (2010)
Pharmacological characterization of GPR55, a putative cannabinoid receptor
Haleli Sharir et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
Ronald J. Ellis et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain
Eva Martin-Sanchez et al.
PAIN MEDICINE (2009)
Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers
Birgit Kraft et al.
ANESTHESIOLOGY (2008)
The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms
Carl Potenzieri et al.
BRAIN RESEARCH (2008)
Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats
M. D. Jhaveri et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain
Wataru Yamamoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid Modulation of Cutaneous Aδ Nociceptors During Inflammation
Carl Potenzieri et al.
JOURNAL OF NEUROPHYSIOLOGY (2008)
Nabilone for the treatment of pain in fibromyalgia
Ryan Quinlan Skrabek et al.
JOURNAL OF PAIN (2008)
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy
Sanjeet Narang et al.
JOURNAL OF PAIN (2008)
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
Barth Wilsey et al.
JOURNAL OF PAIN (2008)
Peripheral cannabinoids attenuate carcinoma-induced nociception in mice
Andre V. Guerrero et al.
NEUROSCIENCE LETTERS (2008)
Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats
Fabiola Voznika Merriam et al.
NEUROSCIENCE LETTERS (2008)
Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study
B. Frank et al.
BRITISH MEDICAL JOURNAL (2008)
Δ9-Tetrahydrocannabinol inhibits electrically-evoked CGRP release and capsaicin-sensitive sensory neurogenic vasodilatation in the rat mesenteric arterial bed
J. D. Wilkinson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
Turo J. Nurmikko et al.
PAIN (2007)
Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers
Mark Wallace et al.
ANESTHESIOLOGY (2007)
Low dose combination of morphine and Δ9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent
Paul A. Smith et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The antinociceptive effect of Δ9-tetrahydrocannabinol in the arthritic rat involves the CB2 cannabinoid receptor
Melinda L. Cox et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The treatment of spasticity with Δ9-tetrahydrocannabinol in persons with spinal cord injury
U. Hagenbach et al.
SPINAL CORD (2007)
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
Nitin Agarwal et al.
NATURE NEUROSCIENCE (2007)
Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision
Alfonso Romero-Sandoval et al.
ANESTHESIOLOGY (2007)
Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial
D. I. Abrams et al.
NEUROLOGY (2007)
Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis
T. Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain
Cheng Liu et al.
JOURNAL OF NEUROPHYSIOLOGY (2006)
Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist
Fumimasa Amaya et al.
PAIN (2006)
Effects of nabilone, a synthetic cannabinoid, on postoperative pain
Pierre Beaulieu
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2006)
Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief
Marcus Schley et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
CB2 cannabinoid receptor mediation of antinociception
Mohab M. Ibrahim et al.
PAIN (2006)
A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management
A Holdcroft et al.
ANESTHESIOLOGY (2006)
Cannabinoid signalling
DG Demuth et al.
LIFE SCIENCES (2006)
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
DR Blake et al.
RHEUMATOLOGY (2006)
Experience with the synthetic cannabinoid nabilone in chronic noncancer pain
DM Berlach et al.
PAIN MEDICINE (2006)
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy
KJ Valenzano et al.
NEUROPHARMACOLOGY (2005)
Recurrent stroke associated with cannabis use
I Mateo et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Are oral cannabinoids safe and effective in refractory neuropathic pain?
N Attal et al.
EUROPEAN JOURNAL OF PAIN (2004)
Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons
J Guo et al.
MOLECULAR PHARMACOLOGY (2004)
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
KB Svendsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
JS Berman et al.
PAIN (2004)
Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury
LM Johanek et al.
PAIN (2004)
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek et al.
LANCET (2003)
Lack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain
DJ Buggy et al.
PAIN (2003)
Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors
A Quartilho et al.
ANESTHESIOLOGY (2003)
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain - A randomized controlled trial
M Karst et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions
M Naef et al.
PAIN (2003)
Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats
G Lim et al.
PAIN (2003)
Short-term effects of cannabinoids in patients with HIV-1 infection - A randomized, placebo-controlled clinical trial
DI Abrams et al.
ANNALS OF INTERNAL MEDICINE (2003)
Cannabis use for chronic non-cancer pain: results of a prospective survey
MA Ware et al.
PAIN (2003)
Cardiovascular consequences of marijuana use
S Sidney
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
The endogenous cannabinoid system controls extinction of aversive memories
G Marsicano et al.
NATURE (2002)
Acute cardiovascular fatalities following cannabis use
L Bachs et al.
FORENSIC SCIENCE INTERNATIONAL (2001)
The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
A Fox et al.
PAIN (2001)
分享论文
